Sonazoid-enhanced ultrasound for preoperative localization and characterization of sentinel lymph nodes in patients with cutaneous melanoma
European Radiology · 2026
DOI: 10.1007/s00330-026-12640-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Radiology, 2026. Verfasst von Binbin Jiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasonography, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer …. Hauptthemen laut MEDLINE: Melanoma, Oxides, Skin Neoplasms, Sentinel Lymph Node. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science Foundation of Peking University Cancer Hospital.
Abstract (Originalsprache)
Objective
Accurate sentinel lymph node (SLN) identification is essential for the staging of cutaneous melanoma. Contrast-enhanced ultrasound using Sonazoid (Sonazoid-CEUS), which is based on a perfluorobutane microbubble contrast agent with reticuloendothelial uptake properties, was evaluated for SLN detection in patients with stage Ib–II melanoma. Materials and methods In this prospective single-arm cohort study, 71 eligible subjects underwent perilesional intradermal Sonazoid-CEUS, followed by lymphoscintigraphy and SLN biopsy. The numbers of SLNs detected via CEUS and lymphoscintigraphy were compared by using non-parametric paired analysis (Wilcoxon signed-rank test). The diagnostic accuracy of CEUS for metastatic involvement was evaluated against histopathological results.
Results
Sonazoid-CEUS achieved a 97.3% success rate in identifying SLNs, detecting 148 SLNs, with an average of 2.1 ± 1.1 SLNs per patient. Most patients (93.0%) had single-basin lymphatic drainage. For metastasis detection, CEUS demonstrated 82.1% sensitivity, 88.4% specificity, and 85.9% accuracy. Ulceration, high mitotic count, and HMB45 positivity in primary lesions were significantly associated with SLN metastasis. No contrast-related adverse events were observed.
Conclusion
Sonazoid-CEUS is a safe and accurate non-radioactive technique for SLN identification and preoperative diagnosis in patients with cutaneous melanoma; moreover, it exhibits potential value as a complementary imaging modality within established SLNB workflows. Key Points Question Can a non-radioactive contrast-enhanced ultrasound technique using Sonazoid improve preoperative localization and characterization of sentinel lymph nodes in patients with cutaneous melanoma?
Findings
In this prospective study, Sonazoid-CEUS identified sentinel lymph nodes in 97.3% of patients and showed high diagnostic accuracy without contrast-related adverse events. Clinical relevance Sonazoid-CEUS provides a non-radioactive adjunct for preoperative sentinel lymph node mapping and characterization in cutaneous melanoma, thereby potentially improving surgical planning while offering complementary functional information alongside conventional lymphoscintigraphy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ultrasonography, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, China.
- Department of Ultrasound, The Second Hospital Affiliated with the Southern University of Science and Technology (Shenzhen Third People's Hospital), Shenzhen, China.
- Department of Melanoma and Sarcoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing, China.
- Department of Bone and Soft Tissue Tumor, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, China.
- Department of Ultrasonography, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, China. yshshmd2013@163.com.
- Peking University Cancer Hospital (Inner Mongolia Campus) & Affiliated Cancer Hospital of Inner Mongolia Medical University, Huhhot, China. yshshmd2013@163.com.
Förderung
- Science Foundation of Peking University Cancer Hospital
Zitieren
APA
Jiang, B., Sun, L., Si, L., Liu, J., Cui, C., Yan, K., & Yin, S. (2026). Sonazoid-enhanced ultrasound for preoperative localization and characterization of sentinel lymph nodes in patients with cutaneous melanoma. European Radiology. https://doi.org/10.1007/s00330-026-12640-2
Vancouver
Jiang B, Sun L, Si L, Liu J, Cui C, Yan K, et al. Sonazoid-enhanced ultrasound for preoperative localization and characterization of sentinel lymph nodes in patients with cutaneous melanoma. European Radiology. 2026. doi:10.1007/s00330-026-12640-2
BibTeX
@article{Jiang2026,
author = {Jiang, Binbin and Sun, Liqi and Si, Lu and Liu, Jiayong and Cui, Chuanliang and Yan, Kun and Yin, Shanshan},
title = {Sonazoid-enhanced ultrasound for preoperative localization and characterization of sentinel lymph nodes in patients with cutaneous melanoma},
journal = {European Radiology},
year = {2026},
doi = {10.1007/s00330-026-12640-2}
}
EUVIMED